Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity.

Vaccine - 8 Sept 2003

Jones Taff, Allard Francine, Cyr Sonya L, Tran Steven P, Plante Martin, Gauthier Joelle, Bellerose Nathalie, Lowell George H, Burt David S

Abstract excerpt

The potential for enhancing the immunogenicity of recombinant (baculovirus-derived) influenza hemagglutinin (rHA) was investigated by comparing the immune responses elicited in mice by an intranasal (i.n.) rHA formulated with Proteosomes, with those induced by intramuscular (i.m.) or i.n. rHA alo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Intranasal
Share to Baculoviridae
Share to Chemistry, Pharmaceutical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemagglutinins

Share to Immunity, Mucosal

Share to Influenza Vaccines

Share to Vaccines, DNA

Share to Vaccines, Synthetic

Source

Identifiers

PMID: 12922101
DOI: 10.1016/s0264-410x(03)00387-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12922101-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity.PMID 12922101Read ↗

Gastrointestinal Delivery of Baculovirus Displaying Influenza Virus Hemagglutinin Protects Mice against Heterologous H5N1 InfectionSemantic proximity Read ↗

Disruption of nasal bacteria enhances protective immune responses to influenza A virus and SARS-CoV-2 infection in miceSemantic proximity Read ↗

Influenza virus-like particle vaccinesSemantic proximity Read ↗

Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1)Semantic proximity Read ↗

Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant.Semantic proximity Read ↗

Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.Semantic proximity Read ↗

Intranasal immunization with influenza vaccine and a detoxified mutant of heat labile enterotoxin from Escherichia coli (LTK63).Semantic proximity Read ↗

A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamstersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.